Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Whitepaper
Clinical Diagnostics
Regulatory Reckoning: Navigating the FDA's Laboratory Developed Tests Regulation White Paper
The FDA's impending LDT rule, slated for finalization in April 2024, ushers in a transformative shift in the regulatory landscape for laboratory-developed tests (LDTs), bringing them under the same stringent oversight as in vitro diagnostics (IVDs).
March 19, 2024
Whitepaper
Clinical Diagnostics
Regulatory Reckoning: Navigating the FDA's Laboratory Developed Tests Regulation White Paper
The FDA's impending LDT rule, slated for finalization in April 2024, ushers in a transformative shift in the regulatory landscape for laboratory-developed tests (LDTs), bringing them under the same stringent oversight as in vitro diagnostics (IVDs).
March 19, 2024
DeciBio Data Insights
Liquid Biopsy
Webinar
Clinical Diagnostics
In the Hot Seat: Challenging Conventions in Precision Medicine Webinar
A dynamic panel discussion featuring key opinion leaders taking the hot seat to share their contrarian thoughts on the most pressing issues in the precision medicine space.
March 18, 2024
Webinar
Clinical Diagnostics
In the Hot Seat: Challenging Conventions in Precision Medicine Webinar
A dynamic panel discussion featuring key opinion leaders taking the hot seat to share their contrarian thoughts on the most pressing issues in the precision medicine space.
March 18, 2024
Cell & Gene Tx
Spatial Omics
Liquid Biopsy
Genomics Market
Clinical Diagnostics
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | February Roundup 2024
Liquid Biopsy (LBx) continued to develop through February, featuring new product launches as well as reimbursement coverage decisions.
March 14, 2024
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | February Roundup 2024
Liquid Biopsy (LBx) continued to develop through February, featuring new product launches as well as reimbursement coverage decisions.
March 14, 2024
Liquid Biopsy
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | February Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of February.
March 5, 2024
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | February Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of February.
March 5, 2024
Next-Generation Therapeutics
In The Press
Pharma & Biotech
The Industry's Positive Outlook For ADCs In 2024
DeciBio sent out its ADC 2024 Industry Outlook Survey. We discussed the results of this survey with BioProcess.
February 27, 2024
In The Press
Pharma & Biotech
The Industry's Positive Outlook For ADCs In 2024
DeciBio sent out its ADC 2024 Industry Outlook Survey. We discussed the results of this survey with BioProcess.
February 27, 2024
adjuvant cell therapy
DeciBio Q&A
Financial Services
Investing in Women's Health: DeciBio Q&A with Alice Zheng, Principal at RH Capital
DeciBio’s Q&A with Alice Zheng, investor at RH Capital, a fund investing in early-stage high-impact companies that are driving innovation, access, and equity across women’s health.
February 20, 2024
DeciBio Q&A
Financial Services
Investing in Women's Health: DeciBio Q&A with Alice Zheng, Principal at RH Capital
DeciBio’s Q&A with Alice Zheng, investor at RH Capital, a fund investing in early-stage high-impact companies that are driving innovation, access, and equity across women’s health.
February 20, 2024
Women's Health
Women in Leadership
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved